Back to Journals » Biologics: Targets and Therapy » Volume 12
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,668 | Dovepress* | 10,500+ | 1,239 | 11,739 | |
PubMed Central* | 1,168 | 537 | 1,705 | ||
Totals | 11,668 | 1,776 | 13,444 | ||
*Since 20 August 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
8 | 0 | 0 | 1 | 2 | 5 |
View citations on PubMed Central and Google Scholar